2017 - CIRTA


This page contains exclusive content for the member of the following sections: TTS, ITA. Log in to view.

4b- Intestinal Failure Outcomes - Neurocognitive and Disease Specific

33.3 - Neuropsychological Outcome in Early School Age Children with Intestinal Failure

Presenter: Anna, Gold, Toronto, Canada
Authors: Anna Gold, Ashley Danguecan, Christina Belza, Yaron Avitzur, Stephanie So, Paul Wales

Neuropsychological Outcome in Early School Age Children with Intestinal Failure

Anna Gold1,2,3, Ashley Danguecan1, Christina Belza2,3, Yaron Avitzur2,3,4, Stephanie So2,3,5, Paul W Wales2,3,6.

1Department of Psychology, The Hospital for Sick Children, Toronto, ON, Canada; 2Transplant and Regenerative Medicine Centre , The Hospital for Sick Children, Toronto, ON, Canada; 3Group For Improvement of Intestinal Failure and Treatment , The Hospital for Sick Children, Toronto, ON, Canada; 4Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, ON, Canada; 5Department of Rehabilitation Services , The Hospital for Sick Children, Toronto, ON, Canada; 6Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, ON, Canada

Purpose: Evaluation of neurocognitive function in children with intestinal failure (IF) is critical to optimize long-term outcomes. Recent research suggests that early cognitive abilities are delayed in this population, although later developmental outcomes are unknown. We examined the neuropsychological outcomes of children with IF at early school-age.

Methods: Prospective single centre neuropsychological assessments of children in an intestinal rehabilitation program between 2012-2016. Transplant recipients were excluded. Assessments included measures of general intellect (WPPSI-IV, WISC-IV/V), academics (WIAT-II/III), learning and memory (CMS, CVLT-C), language (PPVT-4, EVT-2), visual-motor integration (Beery VMI) and fine-motor dexterity (Purdue Pegboard). DSM-IV or V criteria was used to diagnose learning disability (LD), intellectual disability (ID), and/or attention deficit hyperactivity disorder (ADHD). Age-normed scores were correlated with social and medical variables.  

Results: Sample included 28 children (15 males), age 5-8 years, with the following etiologies: necrotizing enterocolitis (NEC) (8), gastroschisis (6), atresia (5), volvulus (4), Hirschsprung’s disease (3), and other (2). 17/28 (61%) were premature (<37 weeks gestational age (GA)) Overall, intellectual functioning was within the low end of normal range (mean Full Scale IQ=89, range: 53-123). 13/28 children (46%) received diagnoses: 8 LD, 3 ID, 2 combined LD and ADHD. Total number of septic episodes in the first year of life (median 2, range 0-7) was significantly correlated with lower scores on most measures, while having a sibling at home was a positive predictor (Table 1). Using linear regression to adjust for GA, total first-year septic episodes remains a significant predictor (p<.05) of working memory, visual-motor and visual memory scores, with a trend for predicting intellectual functioning (p=.067). Additional risk factors significantly correlated with lower scores on ≥2 cognitive functions include: length of hospitalization in first year of life, NEC diagnosis, gestational age, birth weight, and sustained conjugated bilirubin.

Conclusion: Early school-age assessment is important for children with IF, as they are at high risk of learning / attention issues. Medically effective treatment of septic episodes within the first year of life is critical for improving long-term cognitive outcomes. Certain social factors (e.g. sibling at home) are linked with positive outcomes. 


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada